top of page
NEWS
Apr 30, 2024
CMS Finalizes Policy to Facilitate Faster Biosimilar Uptake but Follow-on Policies and Actions Still Needed
The Centers for Medicare & Medicaid Services (CMS) recently released a final rule allowing Medicare Advantage and Part D health plans to...
Apr 2, 2024
Commonsense Policies Needed to Lower Healthcare Costs and Improve Patient Access While Protecting Drug Development Pipeline
Today, President Biden highlighted the administration’s current and future efforts to lower healthcare costs. The good news is recent...
Mar 11, 2024
Vendors Power America's Biopharmaceutical Industry
We Work For Health recently released new employment, vendor and supplier expenditure data that showcases the vital contributions of these...
Mar 7, 2024
President Biden’s State of the Union Call for IRA Expansion Hurts Patients, Workers, and U.S. Leadership
During his State of the Union address Thursday night, President Biden called for Congress to expand the Inflation Reduction Act to...
Feb 29, 2024
House Reviews the ORPHAN Cures Act
On Feb. 29, the House Energy and Commerce Subcommittee on Health held a hearing to review a number of bills that impact those living with...
Oct 30, 2023
The Pill Penalty, Patients and Policymakers
The Centers for Medicare and Medicaid Services is continuing implementation of the Inflation Reduction Act (IRA) by holding “listening...
Aug 4, 2022
A Blown Play: When Congress Treats Patients Like a Political Football, We all Lose
By Rolf Benirschke, National Co-Chair, We Work For Health As a professional football player, I never underestimated the power of a...
Jul 31, 2022
The Far-Reaching Health, Economic & Innovation Impact of Harmful Government Price Setting Policies
By Tom Kowalski, National Co-Chair, We Work For Health This week, Congress is rushing to finalize a massive legislative proposal that...
bottom of page